Osteopenia Terminated Phase 4 Trials for Atazanavir (DB01072)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01902186Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to RaltegravirTreatment